| # | Drug | Count |
|---|---|---|
| 0 | ETANERCEPT | 3 |
| 1 | DABRAFENIB | 2 |
| 2 | TACROLIMUS | 2 |
| 3 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 2 |
| 4 | TACROLIMUS OINTMENT 0.1% | 2 |
| 5 | TRAMETINIB | 2 |
| 6 | ALBUTEROL SULFATE | 1 |
| 7 | ALPRAZOLAM | 1 |
| 8 | ATORVASTATIN CALCIUM | 1 |
| 9 | ATROPINE INJECTION, 2 MG | 1 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ATROPINE INJECTION, 2 MG | 1 | 0.0007 |
| 1 | LAMIVUDINE AND ZIDOVUDINE | 1 | 0.0001 |
| 2 | DABRAFENIB | 2 | 0.0001 |
| 3 | REGORAFENIB | 1 | 0.0001 |
| 4 | PEGFILGRASTIM | 1 | 0.0001 |
| 5 | VEMURAFENIB | 1 | 0.0001 |
| 6 | TRAMETINIB | 2 | 0.0001 |
| 7 | KETOPROFEN | 1 | 0.0001 |
| 8 | ROMIPLOSTIM | 1 | 0.0001 |
| 9 | PROMETHAZINE HYDROCHLORIDE | 1 | 0.0001 |
| # | Drug class | Count |
|---|---|---|
| 0 | Kinase Inhibitor [EPC] | 3 |
| 1 | Tumor Necrosis Factor Blocker [EPC] | 3 |
| 2 | Benzodiazepine [EPC] | 2 |
| 3 | Anti-epileptic Agent [EPC] | 1 |
| 4 | Anticholinergic [EPC] | 1 |
| 5 | Antimetabolite Immunosuppressant [EPC] | 1 |
| 6 | Antimetabolite [EPC] | 1 |
| 7 | Cholinergic Muscarinic Antagonist [EPC] | 1 |
| 8 | Corticosteroid [EPC] | 1 |
| 9 | GLP-1 Receptor Agonist [EPC] | 1 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Thrombopoietin Receptor Agonist [EPC] | 1 | 0.0001 |
| 1 | Anticholinergic [EPC] | 1 | 0.0001 |
| 2 | Antimetabolite Immunosuppressant [EPC] | 1 | 0.0000 |
| 3 | Interleukin-17A Antagonist [EPC] | 1 | 0.0000 |
| 4 | Cholinergic Muscarinic Antagonist [EPC] | 1 | 0.0000 |
| 5 | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 1 | 0.0000 |
| 6 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 1 | 0.0000 |
| 7 | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 1 | 0.0000 |
| 8 | Phosphodiesterase 5 Inhibitor [EPC] | 1 | 0.0000 |
| 9 | Leukocyte Growth Factor [EPC] | 1 | 0.0000 |